Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_assertion type Assertion NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_head.
- NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_assertion description "[These results suggest that PAK1 is essential for the malignant growth of NF2-deficient cells, and that PAK1-blocking drugs could be potentially useful forthe treatment of neurofibromatosis types 2, in addition to Ras-induced cancers and neurofibromatosis type 1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_provenance.
- NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_assertion evidence source_evidence_literature NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_provenance.
- NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_assertion SIO_000772 15000491 NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_provenance.
- NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_assertion wasDerivedFrom befree-20140225 NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_provenance.
- NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_assertion wasGeneratedBy ECO_0000203 NP261903.RAbW2jmc83S4kOQUjW97fVIICnWHJjSnGoMk4Knyxpfac130_provenance.